102 Conversely, a number of groups are advocating with the incorporation of novel markers, such as a advanced karyotype55 or epigenetic subsets, 27,28 into clinical apply. All of these novel prognostic and/or predictive models will have to be validated in cohorts of sufferers addressed with focused brokers.Oleh karena itu, waktu yang tepat untuk be